期刊文献+

乳腺导管原位癌132例诊治分析 被引量:1

原文传递
导出
摘要 目的:探讨乳腺导管原位癌的早期发现、早期诊断及治疗。方法:对我院2003年4月~2013年4月诊治的132例乳腺导管原位癌患者的临床资料进行回顾性分析。结果:132例患者中126例数字化乳腺机有阳性表现,阳性率达95.45%,分别采取肿块扩大切除、单纯乳腺切除、保乳手术、改良乳腺癌根治术及保留皮肤的乳腺癌切除+I期乳房重建,术后病理提示48.48%患者出现局部微浸润;行腋窝淋巴结分期的患者中有4例出现淋巴结转移;术后随访1周~10年,其中一例出现局部复发,其余患者无复发或转移。结论:乳腺原位癌的早期诊断需结合临床和数字化乳腺机、乳管镜等检查发现异常的基础上通过手术活检来实现;手术方式的选择受患者主观意愿的影响较大;对于导管原位癌伴有局部微浸润者是否行腋窝淋巴结分期仍需进一步探讨。
出处 《现代医学》 2014年第1期8-11,共4页 Modern Medical Journal
  • 相关文献

参考文献15

  • 1FISCHER U, BAUM F, OBENAUER S, et al. Comparative study in patients with microcalcification: full-field digital mammography [ J ]. Eur Radio1,2002,12 ( 11 ) :2679-2683.
  • 2KUMAR R, DOROTHY A,SHEAD M S. NCCN clinical prac- tice guidelines in oncology : breast cancer [ M ]. Stanford : NC- CN Guidelines ,2010 : MS-7.
  • 3EDGE S B,BYRD D R,COMFFON C C,et al. AJCC cancer stag- ing manual[M]. 7th ed. New York:Springer Verlag,2010:20.
  • 4Tavassoli FA.乳腺及女性生殖器官肿瘤病理学和遗传学[M].程虹等译.北京:人民卫生出版社,2006.312.
  • 5陈凌,郭晓静,范宇,郎荣刚,臧凤琳,傅西林,付丽.乳腺微浸润癌的临床病理学特征及生物学特性[J].临床与实验病理学杂志,2006,22(5):526-530. 被引量:14
  • 6LEE S K,CHO E Y,KIM W W,et al. The prediction of lymph node metastasis in ductal carcinoma in situ with microinvasion by assessing lymphangiogenesis [ J ]. J Surg Oncol, 2010, 102 (3) :225-229.
  • 7FORTUNATO L, SANTONI M, DRAGO S, et al. Sentinel lymph node biopsy in women with pTla or" microinvasive" breast cancer[ J ]. Breast, 2008,17 ( 4 ) :395-400.
  • 8BANERJEE M, GEORGE J, SONG E Y, et al. Tree- based model for breast cancer prognostication [ J ]. J Clin Oncol, 2004,22 (13) :2567-2575.
  • 9GOLDHIRSCH A, LNGLE J N, GELBER R D, et al. Thresh- olds for therapies : Highlights of the St Gallen International Ex- pert Consensus on the Primary Therapy of Early Breast Cancer 2009 [ J ]. Ann Onco1,2009,20 ( 8 ) : 1319-1329.
  • 10YI M, KRISHNAMURTHY S, KUERER H , et al. Role of primary tumor characteristics in predicting positive sentinel lymph nodes in patients with ductal carcinoma in situ or mi- croinvasive breast cancer [ J ]. Am J Surg, 2008, 196 ( 1 ) : 81-87.

二级参考文献20

  • 1Ellis I O, Tavassoli F A. Microinvasive carcinoma[ M]//Tavassoli F A, Devilee P, eds. World Health Organization classification of tumors. Pathology and genetics, tumors of the breast and female genital organs[ M]. Lyon: IARC Press, 2003.
  • 2Fleming I D. American Joint Committee on Cancer. American Cancer Society. American College of Surgeons. AJCC Cancer Staging manual [ M ]. 5 th ed. Philadelphia : Lippincott -taven, 1997.
  • 3Sliver S A, Tavassoli F A. Mammary ductal carcinoma in situ with microinvasive [ J ]. Cancer, 1998, 82: 2382 - 2390.
  • 4Rosner D, LaneW W, Penetrante R. Ductal carcinoma in situ with microinvasion. A curable entity using surgery alone without need for adjuvant therapy[ J]. Cancer, 1991, 67 : 1498 - 1503.
  • 5Tavassoli F A, Purcell C L, Bratthauer G L, et al. Androgen receptor positivity along with loss of bcl-2, ER, and PR expression in benign and malignant apocrine lesions of the breast. Implications for therapy[J]. Breast J, 1996, 2:1-10.
  • 6Padmore R F, Fowble B, Hoffman J, et al. Microinvasive breast carcinoma: clinicopathologic analysis of a single institution experience[ J]. Cancer, 2000, 88 : 1403 - 1409.
  • 7Prasad M L,Osborne M P,Giri D D,et al. Microinvasive carcinoma (T1 mic ) of the breast : clinicopathologic profile of 21 cases[ J]. Am J Surg Pathol, 2000, 24:422 - 428.
  • 8Zavotsky J, Hansen N, Brennan M B, et al. Lymph node metastasis from ductal carcinoma in situ with microinvasion[ J]. Cancer,1999, 85:2439-2443.
  • 9Yang M, Moriya T, Oguma M, et al. microinvasive ductal carinoma(T1 mic) of the breast. The clinicopathological profile and immunohistochemical features of 28 cases[ J ]. Pathol Int, 2003, 53 :422 - 428.
  • 10Gupta S K, Douglas-Jones A G, Fenn N, et al. The clinical behavior of breast carcinoma is probably determined in the preinvasive stage ( ductal carcinoma in situ) [ J ]. Cancer, 1997, 80:1740 - 1745.

共引文献70

同被引文献8

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部